Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents.

Name: Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents.
Published: 2012
License: Public Domain

Novartis Pharmaceuticals · 2012

ClinicalTrials.gov · Datasets · License: Public Domain · 2012

Open Source ↗

rheumatoid-arthritis

rheumatoid arthritis, rheumatoid arthritis, ra, il-17 blocker, subcutaneous, self-injection, ain457, ain457f, secukinumab, anti-tnfα, pre-filled syringe, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents.

Related documents